Functional dyspepsia. Functional dyspepsia
Conditions
Interventions
Intervention 1: Intervention group:: A capsule containing 500 mg of lemon balm powder, taken twice a day after meals, for a duration of 4 weeks. Intervention 2: Control group: Capsule containing 500 m
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Individuals with functional dyspepsia (according to Rome IV criteria) who have completed the informed consent form and meet the inclusion criteria without meeting the exclusion criteria will be included in the study.
Exclusion criteria
Exclusion criteria: Patients with organic digestive disorders include: peptic ulcer, malignancies of the digestive tract, gallbladder-related pain, celiac disease, chronic pancreatitis, Crohn's disease, eosinophilic gastroenteritis, infiltrative stomach diseases (such as sarcoidosis, lymphoma, and amyloidosis), as well as metabolic disorders, hypercalcemia, heavy metal poisoning, gastroparesis, diabetic radiculopathy, parasites (Giardia, Strongyloides), hepatomegaly, and pregnant and breastfeeding mothers, hypothyroidism.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity score of dyspeptic symptoms. Timepoint: 4 times: upon arrival, after 2, 4, and 8 weeks. Method of measurement: GIS Dyspepsia Symptom Severity Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: 3 times: upon arrival, after 4 and 8 weeks. Method of measurement: Quality of Life Questionnaire in Dyspepsia (NDI).;Symptoms of depression and anxiety. Timepoint: 4 times: upon arrival, after 2, 4, and 8 weeks. Method of measurement: Hamilton Depression and Anxiety Questionnaire.;General temperamental symptoms. Timepoint: At the beginning of the study and week 4. Method of measurement: Doctor Mojahidi's temperament questionnaire.;Symptoms of stomach disorders. Timepoint: At the beginning of the study and week 4. Method of measurement: Stomach temperament questionnaire by Dr. Hosseinzadeh. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBatool Heydari Yazdi
Mashhad University of Medical Sciences
Outcome results
None listed